Aptevo Therapeutics (NASDAQ:APVO) Now Covered by StockNews.com
StockNews.com assumed coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Free Report) in a research report sent to investors on Sunday morning. The firm issued a sell rating on the biotechnology company’s stock. Aptevo Therapeutics Trading Down 3.0% Aptevo Therapeutics stock opened at $0.32 on Friday. The stock has a 50 day moving average of […]
